BioCentury
ARTICLE | Financial News

Epirus completes venture financing

April 21, 2014 7:00 AM UTC

Epirus Biopharmaceuticals Inc., Boston, Mass. Business: Biosimilars, Autoimmune, Antibodies Date completed: 4/16/14 Type: Venture financing Raised: $36 million Investors: Livzon Mabpharm; Adage Capita...